Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F5ZTF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,982
Award facts
- Contract value 100% obligated
- $32,982.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,982.28 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed-price structure. The contract, which carries no set-aside designation, was competitively awarded on February 2, 2026, with an ultimate completion date of February 3, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 31, 2031, which serves as the primary procurement mechanism for pharmaceutical and medical supplies supporting military healthcare programs globally.
AmerisourceBergen, through Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and military treatment facilities. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Eliquis, an anticoagulant medication used for stroke prevention and blood clot treatment, represents the type of essential prescription pharmaceutical that AmerisourceBergen routinely supplies through its federal contracts. The rapid fulfillment timeline reflects the operational nature of delivery orders under the master IDC, enabling efficient resupply of critical medications to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5ZTF?
SPE2DR26F5ZTF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F5ZTF worth?
The government has obligated $32,982 on SPE2DR26F5ZTF.
Is contract SPE2DR26F5ZTF an order under another contract?
Yes. SPE2DR26F5ZTF is a delivery order under SPE2DR25D2109, an indefinite delivery contract.
Was contract SPE2DR26F5ZTF competed?
The extent of competition for SPE2DR26F5ZTF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award